Active ingredients of peptide drugs
In 1923, together with the use of insulin extracted from the pancreas of animals to treat type 1 diabetes, a revolution was created in the use of peptides as medicine. Since insulin drugs had an annual growth rate of 10% due to the prevalence of obesity, the beginning of the development of peptide drugs can be attributed to shorter peptides such as oxytocin, vasopressin, somatostatin, and gonadotropin-releasing hormone.
The importance of peptide drugs is increasing day by day, and in recent years, the interest of pharmaceutical companies to use peptides as drugs is growing rapidly. These drugs are known as a promising solution for the treatment of various diseases such as cancer, diabetes and cardiovascular diseases. The therapeutic use of peptides for other diseases is also evolving, although in the future, anti-cancer therapeutic peptides will occupy the largest share of the market.
One of the most important features of peptide drugs is their effectiveness, selectivity, stability and high immunogenicity.